Seeing Is Believing
with an average price target of $5.79. This is a potential upside of $4.31 (291.22%) from yesterday's end of day stock price of $1.48.
Achilles Therapeutics PLC ADR's activity chart (see below) currently has 10 price targets and 19 ratings on display.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 05-Apr-2024. First documented stock forecast 26-Apr-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
1 years 6 months 19 days ago
(05-Apr-2024)
0/1 (0%)
$10.25 (61.19%)
Hold
$2
$0.52 (35.14%)
1 years 6 months 20 days ago
(04-Apr-2024)
0/5 (0%)
$1.1 (122.22%)
Sell
$0.5
$-0.98 (-66.22%)
$20
1 years 10 months 10 days ago
(14-Dec-2023)
0/2 (0%)
$-0.36 (-41.86%)
Buy
2 years 10 months 18 days ago
(06-Dec-2022)
0/1 (0%)
$6.25 (37.31%)
What is ACHL (Achilles Therapeutics PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on ACHL (Achilles Therapeutics PLC ADR) with a proven track record?
Which analyst has the current lower performing score on ACHL (Achilles Therapeutics PLC ADR) with a proven track record?
Which analyst has the most public recommendations on ACHL (Achilles Therapeutics PLC ADR)?
Which analyst is the currently most bullish on ACHL (Achilles Therapeutics PLC ADR)?
Which analyst is the currently most reserved on ACHL (Achilles Therapeutics PLC ADR)?